Print

BioClinica, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results  
2/7/2013 6:43:58 AM

BioClinica®, Inc. (NASDAQ: BIOC), a leading global provider of clinical trial management solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2012.

Financial highlights for the quarter ended December 31, 2012 include:

• Service revenues increased 20.9% to $22.2 million as compared with $18.3 million for the same period 2011.

//-->